Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1436

PF07275315-TSLP-hIgG1

Home » Antibodies » PF07275315-TSLP-hIgG1

Background of PF07275315-TSLP-hIgG1

Distinguished as a tri-specific monoclonal antibody, PF-07275315 exerts its therapeutic effect by targeting three key entities: thymic stromal lymphopoietin (TSLP), interleukin 4 (IL-4), and interleukin 13 (IL-13). By engaging with these specific targets, PF-07275315 aims to modulate the underlying immune pathways implicated in the pathogenesis of atopic dermatitis, thereby offering potential relief for affected individuals.

Specifications

Catalog Number:
KB-1436
Antibody Name:
PF07275315-TSLP-hIgG1
Isotype:
Human IgG1,lambda
FC Muations:
Target:
TSLP
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis.
  2. PF-07275315 by Pfizer for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval.